Utah Medical Products(NASDAQ:UTMD) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during Pre-market on Jul 26, 2016. Earnings per share were $0.86.
Utah Medical Products (UTMD) shares turned negative on Fridays trading session with the shares closing down -0.68 points or -1.03% at a volume of 6,383. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $65.7. The peak price level was also seen at $65.7 while the days lowest was $65.04. Finally the shares closed at $65.07. The 52-week high of the shares is $68.9 while the 52-week low is $50. According to the latest information available, the market cap of the company is $245 M.
Several Insider Transactions has been reported to the SEC. On Jun 1, 2016, Paul O Richins (VP, Treasurer, Asst Secretary) sold 396 shares at $64.50 per share price.
Utah Medical Products Inc. (UTMD) is engaged in the business of producing medical devices. UTMD markets a range of medical devices used in critical care areas: neonatal intensive care unit (NICU) labor and delivery (L&D) department and women’s health center in hospitals as well as products sold to outpatient clinics and physician’s offices. Its products include INTRAN INTRAN PLUS TENDER TOUCH AROM-COT CORDGUARD Bari-Belts Bari-Bands BT-Cath DISPOSA-HOOD DELTRAN PLUS UMBILI-CATH NUTRI-CATH and NUTRI-LOK among others. UTMD’s product and process development projects are in the areas of augmentation and internal manufacturing of Femcare devices; specialized procedures for the assessment and treatment of cervical/uterine disease and product and process development for original equipment manufacturers (OEMs). Its products are sold to clinical end user facilities through specialty distributors national hospital distribution companies and other medical device manufacturers.